Resveratrol suppresses the c-Myc/miR-17 pathway in breast cancer cells to upregulate major histocompatibility complex class I chain-related proteins A and B (MICA and MICB) that promote antitumor immune responses by increasing cytolysis of breast cancer cells by natural killer (NK) cells (28). The gene discussed is MYC; the disease is breast carcinoma.